Bioavailability of potassium from a slow-release tablet
Ben-Ishay, D.; Engelman, K.
Clinical Pharmacology and Therapeutics 14(2): 250-258
1973
ISSN/ISBN: 0009-9236 PMID: 4695385 DOI: 10.1002/cpt1973142250
Accession: 042386379
The bioavailability of potassium (K) from orally administered 10 per cent potassium chloride (KCI) solution has been compared with that from a slow-release KCl tablet (Slow-K) in 10 normal subiects under metabolic balance conditions. After a single 40 m Eq. KCl dose, urinary K increased sooner and to greater peak levels after the solution was administered. In both cases greater amounts of K appeared in the urine when administered in the fasting than in the postprandial state.
PDF emailed within 0-6 h: $19.90
Related References
Kienzler, J.L.; Magnette, J.; Refouvelet, B.; Xicluna, A.; Brunet Lecomte, P.; Bechtel, P. 1995: Bioavailability of 3 formulations of pseudo-ephedrine EFIDAC/24, a 24h-slow-release tablet, in comparison with sudafed, an immediate-release tablet, and NASA-12, A 12h-slow-release capsule Therapie (Paris) 1995(Suppl ): 488Rivera-Calimlim, L.; Calimlim, J.F.; Liang, R.; Lasagna, L.; Diamond, G.L. 1986: Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability Journal of Asthma: Official Journal of the Association for the Care of Asthma 23(3): 113-122
Hayashi, H. 1986: Etude comparative du gluconate de potassium en comprimé et du chlorure de potassium forme retard dans l'hypokaliémie - Comparative study on effect of KGS normal potassium gluconate tablet and slow release potassium chloride tablet on hypokalemia Yakuri to Chiryo 14(5): 379-389
De Salazar, L.; Segarra, I.; López-Román, F.J.; Torregrosa-García, A.; Pérez-Piñero, S.; Ávila-Gandía, V. 2021: Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet Pharmaceutics 13(9)
Lowance, D.C.; Murad, F.; Darrow, W.R.; Bonus, L. 1982: Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement International Journal of Clinical Pharmacology Therapy and Toxicology 20(5): 204-208
Betlach, C.J.; Arnold, J.D.; Frost, R.W.; Leese, P.T.; Gonzalez, M.A. 1987: Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet Pharmaceutical Research 4(5): 409-411
Kumar, P.D. 1992: Comparative bioavailability of slow release dicbfenac (Voveran SR) with enteric coated tablet and internationally used Voltaren retard Journal of the Association of Physicians of India 40(7): 483
Sahajwalla, C.G.; Bhatt, A.D.; Bhatia, S.C.; Bakshi, R.; Doshi, K.J.; Banavalikar, M.M.; Bharucha, E.D.; Marthak, K.V.; Shah, N.N.; Gupta, K.C. 1991: Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard Journal of the Association of Physicians of India 39(7): 546-548
Lambert, J.R.; Newman, A. 1980: Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy American Journal of Gastroenterology 73(6): 508-511
Arnold, J.; Jacob, J.T.; Riley, B. 1980: Bioavailability and pharmacokinetics of a new, slow-release potassium chloride capsule Journal of Pharmaceutical Sciences 69(12): 1416-1418
Bende, G.; Biswal, S.; Bhad, P.; Chen, Y.; Salunke, A.; Winter, S.; Wagner, R.; Sunkara, G. 2016: Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation Clinical Pharmacology in Drug Development 5(1): 76-82
Bouckaert, S.; Lefebvre, R.A.; Colardyn, F.; Remon, J.P. 1992: Influence of the application site on bioadhesion and slow-release characteristics of a buccal bioadhesive miconazole slow-release tablet Pharmaceutical Research (New York) 9(10 Suppl): S243
Bouckaert, S.; Lefebvre, R.A.; Colardyn, F.; Remon, J.P. 1993: Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole European Journal of Clinical Pharmacology 44(4): 331-335
Bass, A.; Stark, J.G.; Pixton, G.C.; Sommerville, K.W.; Zamora, C.A.; Leibowitz, M.; Rolleri, R. 2012: Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers Clinical Therapeutics 34(7): 1601-1612
Menon, R.; Tolbert, D.; Cefali, E. 2007: The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet Biopharmaceutics and Drug Disposition 28(6): 297-306
Ullah, M.; Murtaza, G.; Hussain, I. 2016: Relative Bioavailability Study of Succinic Acid Cocrystal Tablet and Marketed Conventional Immediate Release Tablet Formulation of Carbamazepine 200 Mg in Rabbits Acta Poloniae Pharmaceutica 73(5): 1412
Gai, M.N.; Costa, E.; Arancibia, A. 2009: Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability International Journal of Clinical Pharmacology and Therapeutics 47(4): 269-274
Ahmed, I.S.; Fatahalla, F.A. 2007: Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet Drug Development and Industrial Pharmacy 33(5): 505-511
Abbas, R.; Palumbo, D.; Walters, F.; Belden, H.; Berry, S.A. 2016: Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared with Immediate-release Methylphenidate Chewable Tablet Clinical Therapeutics 38(5): 1151-1157
Whiting, S.J.; Gorecki, D.K.; Jones, D. 1991: In vitro and in vivo assessment of the bioavailability of potassium from a potassium tartrate tablet Biopharmaceutics and Drug Disposition 12(3): 207-213